Journal article

Epidemiology, treatment and outcomes of bloodstream infection due to vancomycin-resistant enterococci in cancer patients in a vanB endemic setting

Ouli Xie, Monica A Slavin, Benjamin W Teh, Ashish Bajel, Abby P Douglas, Leon J Worth

BMC INFECTIOUS DISEASES | Springer Nature | Published : 2020


Background: Vancomycin-resistant enterococcus (VRE) is an important cause of infection in immunocompromised populations. Few studies have described the characteristics of vanB VRE infection. We sought to describe the epidemiology, treatment and outcomes of VRE bloodstream infections (BSI) in a vanB predominant setting in malignant hematology and oncology patients. Methods: A retrospective review was performed at two large Australian centres and spanning a 6-year period (2008–2014). Evaluable outcomes were intensive care admission (ICU) within 48 h of BSI, all-cause mortality (7 and 30 days) and length of admission. Results: Overall, 106 BSI episodes were observed in 96 patients, predominantl..

View full abstract